Sjogren's syndrome (SS) is characterized by lymphocytic infiltration of the salivary glands leading to a variety of dental complications. This project focuses on molecular abnormalities in IL-2 biology involving SS T cells. T lymphocytes from SS peripheral blood are hyporesponsive to mitogenic and antigenic stimuli, whereas T lymphocytes infiltrating the SS salivary glands actively produce IL-2. Some of these are older observations based on cell activation markers; others are recent findings from our own laboratory measuring transcription factors or using PCR amplification in SS salivary gland tissue. The current specific aims which follow are designed to further analyze abnormalities of signal transduction in relation to a defect in the Oct. 1 transcription factor necessary for IL-2 gene activation, to continue our analysis of cytokine profiles using PCR, and to develop new therapeutic modalities for SS.
Specific aims : 1. The expression of nuclear proteins binding to cognate DNA sequences in the IL-2 gene promoter region (transcription factors) will be assessed by electrophoretic mobility shift assay. This signaling event is putatively the most distal in the pathway. Therefore, abnormalities detected would support our hypothesis that an early signaling defect in calcium contributes to the reduced biosynthesis of IL-2. 2. Specific mRNAs for the gene encoding IL-2 will be studied in SS salivary glands using the PCR. Demonstration of inflammatory cytokines such as IL-2 in SS tissues could provide an explanation for the intense lymphocytic infiltration and tissue destruction. 3. Normalization of IL-2 biosynthesis, as well as the expression of proteins involved in the regulation of the IL-2 gene, will be attempted using drugs known to enhance T cell activation. Aspirin-like drugs that enhance L-2 production and both early and late signaling events will be studied.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE009311-05
Application #
2130501
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Project Start
1990-07-01
Project End
1996-08-31
Budget Start
1994-09-15
Budget End
1995-08-31
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Kong, L; Ogawa, N; McGuff, H S et al. (1998) Bcl-2 family expression in salivary glands from patients with primary Sjogren's syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol 88:133-41
Kong, L; Robinson, C P; Peck, A B et al. (1998) Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol 16:675-81
Kong, L; Ogawa, N; Nakabayashi, T et al. (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 40:87-97
Nakabayashi, T; Letterio, J J; Geiser, A G et al. (1997) Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice. J Immunol 158:5527-35
Ogawa, N; Dang, H; Kong, L et al. (1996) Lymphocyte apoptosis and apoptosis-associated gene expression in Sjogren's syndrome. Arthritis Rheum 39:1875-85
Flescher, E; Vela-Roch, N; Ogawa, N et al. (1996) Abnormality of Oct-1 DNA binding in T cells from Sjogren's syndrome patients. Eur J Immunol 26:2006-11
DeKeyser, F; DeKeyser, H; Kazatchkine, M D et al. (1996) Pooled human immunoglobulins contain anti-idiotypes with reactivity against the SLE-associated 4B4 cross-reactive idiotype. Clin Exp Rheumatol 14:587-91
Anaya, J M; Ogawa, N; Talal, N (1995) Sjogren's syndrome in childhood. J Rheumatol 22:1152-8
Anaya, J M; Liu, G T; D'Souza, E et al. (1995) Primary Sjogren's syndrome in men. Ann Rheum Dis 54:748-51
Ogawa, N; Dang, H; Talal, N (1995) Apoptosis and autoimmunity. J Autoimmun 8:1-19

Showing the most recent 10 out of 28 publications